FDA finalizes guidance on alternative inspection tools
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionComplianceEnforcementGMPPharmaceuticalsQuality Assurance and ControlRemote interactive evaluationUnited StatesUS Food and Drug Administration (FDA)